rs111033254
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000441.2(SLC26A4):c.1588T>C(p.Tyr530His) variant causes a missense change. The variant allele was found at a frequency of 0.0000317 in 1,609,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y530S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1588T>C | p.Tyr530His | missense_variant | 14/21 | NM_000441.2 | ENSP00000494017.1 | |||
SLC26A4 | ENST00000477350.5 | n.435T>C | non_coding_transcript_exon_variant | 4/5 | 4 | |||||
SLC26A4 | ENST00000480841.5 | n.437T>C | non_coding_transcript_exon_variant | 5/8 | 3 | |||||
SLC26A4 | ENST00000644846.1 | n.298T>C | non_coding_transcript_exon_variant | 4/10 | ENSP00000494344.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251182Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135754
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1456946Hom.: 0 Cov.: 28 AF XY: 0.0000331 AC XY: 24AN XY: 725130
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
Pendred syndrome Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 04, 2022 | Variant summary: SLC26A4 c.1588T>C (p.Tyr530His) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251182 control chromosomes. c.1588T>C has been reported in the literature as a biallelic genotype in multiple individuals affected with Pendred syndrome (example, Coyle_1998, Borck_2003, Albert_2006). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrating an effect on protein trafficking due to retention in the endoplasmic reticulum (ER) (Choi_2009). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | curation | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Feb 01, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2009 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jan 27, 2016 | The c.1588T>C (p.Tyr530His) missense variant in the SLC26A4 gene has been reported as a common deleterious variant associated with Pendred Syndrome (Coyle et al., 1998; Blons et al., 2004). This variant has been reported in several affected individuals, often in trans with a second deleterious variant (V138F, T410M, c.2089+1G>A, V422D, T416P, Y78C, F355S) (Blons et al., 2004; Banghova et al., 2008; Borck et al., 2009; Ladsous et al., 2014). Functional studies have shown this variant affects protein localization within the cell; additionally, some affected individuals harboring this variant have elevated thyroglobulin (Choi et al., 2009; Ladsous et al., 2014). This variant is reported at low frequency within the control population databases (Exome Sequencing Project [ESP] = NA; 1000 Genomes = NA; and ExAC = 0.002). Multiple in silico algorithms predict the variant to have a deleterious effect (GERP = 5.96; CADD = 26.2; PolyPhen = 1; SIFT = 0.02). In addition, reputable diagnostic laboratories have reported this variant as Pathogenic.Therefore, this collective evidence supports the classification of the c.1588T>C (p.Tyr530His) as an autosomal recessive Pathogenic variant for Pendred Syndrome/ Non-syndromic Hearing Loss DFNB4. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Jan 21, 2015 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 06, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 16570074, 26683941, 26485571, 17876604, 33199029, 27861301, 19204907, 19040761, 24224479, 12788906, 9618167, 26969326, 15689455, 11317356, 36147510, 14679580, 15355436) - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 530 of the SLC26A4 protein (p.Tyr530His). This variant is present in population databases (rs111033254, gnomAD 0.004%). This missense change has been observed in individual(s) with Pendred syndrome (PMID: 9618167, 12788906, 19204907, 24224479, 26969326). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4836). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC26A4 function (PMID: 19204907). For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Jul 10, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 27, 2024 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 26, 2015 | The p.Tyr530His variant in SLC26A4 has been reported in at least 20 individuals with hearing loss with EVA and/or Mondini dysplasia or with Pendred syndrome (Al bert 2006, Banghova 2008, Blons 2004, Borck 2003, Campbell 2001, Choi 2009, Coyl e 1998, Prasad 2004, Pryor 2005, LMM unpublished data). The variant was compound heterozygous in at least 14 of those probands. This variant was present in 1/6 6632 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://e xac.broadinstitute.org; dbSNP rs111033254). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a r ecessive carrier frequency. One study has shown that the Tyr530His variant impa cts protein function (Choi 2009). In summary, this variant meets our criteria to be classified as pathogenic (http://personalizedmedicine.partners.org/). - |
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at